Jubilant Ingrevia said that its board has approved the company’s entry into a binding term sheet with Zettaone Technologies India for the acquisition of a 40% strategic equity stake in Zettaone for a total consideration of Rs 189.2 crore.
Read more at the source
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.